NFKB1 and COVID-19: Several reported anti‐inflammatory or antiviral drugs for COVID‐19, such as HCQ, macrolide antibiotics, dexamethasone, and N‐acetylcysteine, are related to NF‐κB inhibition.183, 184, 185, 186